NCT00285597View on ClinicalTrials.gov

Ursodeoxycholic Acid in Chronic Heart Failure

PHASE2UnknownINTERVENTIONAL

Timeline

Start Date

May 31, 2004

Study Completion Date

January 31, 2006

Conditions

Heart Failure, Congestive

Interventions

DRUG

Ursodeoxycholic Acid

Trial Locations (1)

SW3 6LY

National Heart and Lung Institute, London

Sponsors

Collaborators (1)

Dr. Falk Pharma GmbH

All Listed Sponsors

collaborator

Dr. Falk Pharma GmbH

INDUSTRY

lead

National Heart and Lung Institute

OTHER